David Brieger results 1
· Newest (Page 1/1, per page 25)
Author: David Brieger ×Clear All Filters
Search Results
Purpose To investigate trends in SGLT2i and GLP-1RA use in Australia in the era of increased evidence of their cardiovascular benefits. Methods We used national dispensing claims for a 10% random sample of Australians to estimate the number of prevalent and new users (no dispensing in the prior year) of SGLT2i or GLP-1RA per month from January 2014 to July 2022. We assessed prescriber specialty and prior use of other antidiabe...
Previous1Next